Roche Holding (RHHBY) Stock Overview

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, and internationally. The company offers pharmaceutical products in the therapeutic areas of oncology, neuroscience, infectious diseases, immunology, hemophilia, ophthalmology, dermatology, respiratory, anemia, inflammatory and autoimmune, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, cardiovascular, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. It has a research collaboration agreement with Synlogic, Inc. for the discovery of a novel synthetic biotic for the treatment of inflammatory bowel disease (IBD); and strategic agreement with Alnylam Pharmaceuticals, Inc. to develop and commercialize zilebesiran. Roche Holding AG was founded in 1896 and is headquartered in Basel, Switzerland.

RHHBY Stock Information

SymbolRHHBY

Address

Grenzacherstrasse 124Basel, 4058Switzerland

Founded-

Trading hours-

Websitehttps://www.roche.com

Country🇨🇭 Switzerland

Phone Number41 61 688 11 11

Roche Holding (RHHBY) Price Chart

Roche Holding Overview: Key Details and Summary

Stock data	2023	Change
Price	$33.46	N/A
Market Cap	$213.78B	N/A
Shares Outstanding	6.39B	-0.17%
Employees	103.61K	N/A
Shareholder Equity	33.26B	3.90%

Valuation	2023	Change
P/S Ratio	3.17	N/A
P/B Ratio	6.43	N/A
P/FCF	16.75	N/A

Dividends	2023	Change
Dividend Yield	3.96%	N/A
Dividend per share	1.3249	N/A
Dividend Payout Ratio	0.6142	N/A

Growth	2023	Change
ROIC	0.1886	N/A
CAPEX	-3.98B	N/A
Return on Equity	0.4143	N/A

Earnings	2023	Change
Revenue	$67.41B	N/A
Earnings	$13.78B	N/A
Free Cash Flow	$12.77B	N/A
Gross Margin	0.7294	N/A
Operating Margin	0.2547	N/A
Net income margin	0.2045	N/A
FCF Margin	0.1894	N/A

Financial Strength	2023	Change
Total Assets	$100.90B	N/A
Total Debt	$34.33B	N/A
Cash on Hand	$11.72B	N/A
Debt to Equity	$1.92	-1.92%
Cash to Debt	0.3414	-7.21%
Current Ratio	$1.35	8.53%